Elsevier

World Neurosurgery

Volume 107, November 2017, Pages 168-174
World Neurosurgery

Original Article
Anatomic Targeting of the Optimal Location for Thalamic Deep Brain Stimulation in Patients with Essential Tremor

https://doi.org/10.1016/j.wneu.2017.07.136Get rights and content

Background

Thalamic deep brain stimulation (DBS) is an effective strategy for treatment of essential tremor (ET). With limitations of imaging modalities, targeting largely relies on indirect methods. This study was designed to determine the optimal target for DBS in ET and construct a targeting method based on probabilistic maps.

Methods

Patients with ET who had sustained tremor reduction at 1 year and optimal microelectrode recordings were selected. Stimulation volume was individually modeled in standard space, and a final optimal region was derived for the whole population. A fornix (FX) targeting method was developed to determine the location of the optimal stimulation site relative to the FX and posterior commissure (PC) in the anteroposterior plane, the border between the thalamus and internal capsule in the mediolateral plane, and the anterior commissure (AC)–PC (AC-PC) plane in the dorsoventral axis. Following comparative analyses with other standard indirect methods (25% of AC-PC and PC + 6 mm), the FX method was studied in relation to diffusion tensor imaging.

Results

Using the FX method, the optimal stimulation site was at the intersection of two thirds and one third of the PC-FX distance (mean of 28% ± 1.5 AC-PC length) and 4 mm medial to the lateral border of the thalamus. Compared with previously used methods, there was a significant reduction in variability of the optimal stimulation site with the FX method. The target defined using this strategy was found to be within the boundaries of the dentatorubrothalamic tract.

Conclusions

The FX method may be an additional targeting strategy in patients undergoing thalamic DBS surgery.

Introduction

Long-term stimulation of the ventral intermediate nucleus (Vim) of the thalamus has been shown to be effective for the surgical treatment of medically refractory tremor.1, 2 The Vim as a target was initially selected for lesioning and subsequently for deep brain stimulation (DBS).3 In this thalamic region, movement-related kinesthetic and tremor cells coexist,4, 5, 6 rendering electrophysiology a main strategy for targeting the Vim.2, 7 Precisely targeting the Vim is crucial for long-term improvement of tremor. Previous studies have shown that even small deviations from the optimal location may result in a suboptimal outcome.8, 9

As currently used in the clinic, structural magnetic resonance imaging (MRI) is not able to visualize thalamic nuclei, even with specialized sequences or diffusion imaging.10, 11, 12 Commonly used approaches to target the Vim are based on formulaic methods that derive coordinates relative to the anterior commissure (AC) and posterior commissure (PC).8, 13, 14 However, such approaches are insensitive to the variability of thalamic morphology and the size of the third ventricle. Both factors can contribute to errors in correctly identifying the Vim, which may ultimately lead to a suboptimal outcome. Our aim was to determine the optimal target for chronic DBS for essential tremor (ET) and construct an anatomic targeting method based on this probabilistic map to overcome the limitations in identifying thalamic subdivisions on MRI sequences.

Section snippets

Study Population

The study was approved by the institutional review board of the University Health Network. Records of patients with ET treated with Vim DBS at Toronto Western Hospital within the last 5 years were reviewed. To develop our targeting-based system, we selected patients who met 3 inclusion criteria. First, patients needed to have disabling medically refractory ET, as determined by a movement disorders neurologist. Second, intraoperative microelectrode recording had to show the presence of

Optimal Location of Stimulation

At 1 year, the distribution of the active contacts with reference to the electrode array in the patients included in our initial analysis was as follows: contact 0 in 1 patient, contact 1 in 5 patients, contact 2 in 2 patients, and contact 3 in 2 patients. Stimulation settings were 2.6 V ± 0.9, 66 μs ± 13, and 155 Hz ± 27. The optimal stimulation area based on the estimated volume of activation that maximized clinical tremor reduction and minimized side effects is shown in Figure 1. This

Discussion

This study shows that the optimal location for long-term DBS in ET comprises a region that is likely within the Vim near its anterior border. Based on a probabilistic map, we designed an anatomic FX method similar in principle to the anatomic targeting that has been used to locate the subthalamic nucleus. In the latter instance, a more easily identifiable structure on MRI, the red nucleus, was used to approximate the less readily identifiable subthalamic nucleus.22 In our analysis, the FX

Conclusions

We compared several methods that can be used to target the optimal location for long-term stimulation for tremor. The newly described FX method seems to be more precise, corresponds well to the DRT, and can be easily translated into current clinical practice. Although further validation is required, the FX method may be a complementary strategy to help surgeons targeting the optimal location for placement of DBS electrodes in patients with tremor.

References (24)

  • F.A. Lenz et al.

    Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells

    Brain

    (1994)
  • E. Papavassiliou et al.

    Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome

    Neurosurgery

    (2004)
  • Cited by (0)

    Conflict of interest statement: C.H. has received honoraria from Medtronic and St. Jude Medical, Inc. A.F. has given expert testimony for Medtronic; has served on scientific boards of AbbVie, Inc., and UCB; and has received honoraria from Teva Pharmaceuticals, Ltd., UCB, Medtronic, AbbVie, Inc., Boston Scientific, and Chiesi Farmaceutici. A.M.L. receives consulting fees from Medtronic, Boston Scientific, St. Jude Medical, Inc., and Eli Lilly and Company and holds an interest in Functional Neuromodulation, Inc. The remaining authors have no conflicts to report.

    View full text